Background: Newly synthesised peptide-receptive major histocompatibility complex (MHC) class I molecules form a transient loading complex in the endoplasmic reticulum with the transporter associated with antigen processing (TAP) and a set of accessory proteins. Binding of peptide to the MHC class I molecule is necessary for dissociation of the MHC class I molecule from the complex with TAP, but other components of the complex might also be involved. To investigate the role of TAP in this process, mutations that block nucleotide binding were introduced into the ATP-binding site of TAP.
Background
ATP-binding cassette (ABC) transporters use the energy of ATP hydrolysis to drive a variety of substrates through cellular membranes. All have, in common, a four-domain structure comprising two transmembrane and two nucleotide-binding domains (NBDs) with extensively conserved sequence elements, and represent the largest gene family. The transporter associated with antigen processing (TAP) is a heterodimeric member of the superfamily. TAP is localised in the membrane of the vertebrate endoplasmic reticulum (ER) and is a critical part of the machinery of antigen presentation associated with major histocompatibility complex (MHC) class I molecules. TAP transports short peptides, generated in the cytosol by the proteasome, into the ER lumen where they load into the peptide-binding groove of MHC class I molecules. TAP forms a 'loading complex' with newly-formed MHC class I molecules through a bridging protein, tapasin, and two chaperones, calreticulin and ERp57. The apparent stoichiometry of the complex is 1 TAP:4 tapasin-MHC class I-calreticulin [1] .
Binding of the MHC class I molecule to peptide causes the MHC class I molecule to dissociate from the loading complex [2, 3] . This dissociation is peptide-specific with respect to the MHC class I allele involved [2] [3] [4] , suggesting that a peptide-induced conformational change in the MHC class I molecule [5] itself triggers undocking from the TAP complex. Here, we investigated the proposal by Elliott [6] that conformational changes in TAP -driven, as in other members of the ABC transporter family, by binding and hydrolysis of ATP during the transport cycle -might promote the undocking of loaded MHC class I molecules.
To disrupt nucleotide binding by TAP, we introduced mutations within TAP at a sequence motif known as the Walker A site. We found that nucleotide binding by TAP was indeed required for peptide-mediated dissociation of the MHC class I molecule from the TAP complex. Our findings also suggest that the uptake of peptide substrates by TAP depends strictly on conformational properties determined by the nucleotide-binding state. We propose a kinetic model in which nucleotide binding by TAP coordinates the uptake and subsequent transport of peptides with the binding, loading and release of MHC class I molecules from the loading complex.
Results

Mutant transporters form normal loading complexes but lack nucleotide-binding and peptide-transport activity
Expression of wild-type rat TAP in the TAP-deficient human cell line T2 restores normal assembly and surface expression of MHC class I molecules [7] . In such cells, the human MHC class I molecules, tapasin and calreticulin form a loading complex with rat TAP [8] . We reconstituted T2 cells with mutant rat TAP cDNAs in which the nucleotide-binding sites of the two TAP chains, TAP1 and TAP2, had both been disrupted. In the TAP mutants that we designate MUT I, we replaced the glycine residues in the Walker A motif -at positions 515 and 520 in the case of TAP1, and 503 and 508 in the case of TAP2 -with valine. In the MUT II mutants, the same glycine residues were replaced in both TAP chains with serine. Both glycines have a very high level of conservation in the Walker A motif [9] and contribute to the binding site for β-phosphate and γ-phosphate of nucleotides [10] . Furthermore, replacement of the glycines by serine or valine is known to destroy function in other ABC transporters [11, 12] . The characteristics of the parental T2 cell line and T2 transfectants expressing wild-type or mutant TAP (MUT I and MUT II) are shown in Figures 1 and 2 .
Western blots of cell lysates confirmed expression of both TAP chains in the transfectants (Figure 1a ). T2 cells transfected with MUT II appeared consistently to express somewhat lower levels of TAP than T2 cells transfected with wild-type TAP or the MUT I mutant. Nevertheless, both mutant TAPs were physically assembled and could form loading complexes comprising MHC class I molecules, tapasin, ERp57 and calreticulin that were indistinguishable from those formed by wild-type TAP (Figure 1b) . Thus, the mutations in the NBDs of TAP had no apparent effect on the formation of the loading complex.
To compare the nucleotide-binding activity of wild-type and mutant TAP chains, aliquots of detergent-solubilised cell membranes of the T2 transfectants were incubated with different nucleotide-agarose resins (ATP, ADP and AMP). Retained proteins were eluted with SDS-containing buffer and analysed by western blot probed for TAP1 and TAP2 (Figure 2a ). Wild-type TAP was bound to agaroseimmobilised ATP and ADP but not to AMP. The specificity of TAP binding was confirmed by competition experiments with free ATP (data not shown). No ATPbinding activity was demonstrable for the two mutant transporters and only a marginal binding to ADP-agarose could be observed for MUT I (TAP2) and MUT II (TAP1 or TAP2). In the case of T2 cells transfected with MUT I, some ADP binding was detectable for TAP1after a twofold longer exposure (data not shown). Because of the weak signal strength, variation in ADP binding is most likely due to experimental limitations of the western blot technique.
Peptide transport from cytosol to ER by the mutant TAPs compared with the wild type was analysed in permeabilised cells with a standard peptide-transport assay [13] using the radioiodinated model peptide S8 (TVDNKTRYR, in the single-letter amino-acid code) [14] . No peptide transport was found in the two mutant cell lines above the background detected in untransfected T2 cells ( Figure 2b ).
As expected from the lack of peptide transport, the mutant TAPs were unable to support maturation of MHC class I molecules in the transfectants. In pulse-chase experiments, human leukocyte antigen HLA-B5 molecules in T2 cells transfected with wild-type TAP acquired resistance to endonuclease H, signalling exit from the ER, with a half-life of about 90 minutes (Figure 3a) . In contrast, in T2 cells expressing MUT I or MUT II, HLA-B5 molecules remained sensitive to endonuclease H during the whole chase period. The initial intensity of the signal Immunoblots showing the presence of TAP2, TAP1, calreticulin, ERp57, tapasin and MHC class I molecules in the loading complex in digitoninlysed T2 transfectants after immunoprecipitation (IP) with anti-rat TAP2 antiserum. Western blots were probed with antisera to TAP2, TAP1, calreticulin, ERp57, tapasin and MHC class I molecules as indicated. Dissociation of MHC class I molecules from TAP can be triggered in vitro by incubation with suitable peptides that bind MHC class I molecules [2] [3] [4] . We incubated digitonin-solubilised T2 transfectants at 37°C with a 1:1 mixture of the peptides LLDVPTAAV and QPRAPIRPI, which bind HLA-A2 and HLA-B5, respectively [15, 16] , in increasing concentrations. Complexes associated with TAP were then isolated with anti-TAP2 antiserum and analysed by western blotting (Figure 4a ). HLA class I molecules were released from wild-type TAP in a peptidedependent fashion. At 100 µM peptide, nearly no MHC class I molecules were found in the TAP complex. Consistent with this result, we found, in stabilisation experiments in vitro, that the effective loading concentration of MHC class I molecules for these two peptides was 10-100 µM (see supplementary material published with this article on the internet). In contrast, no peptide-mediated release of MHC class I molecules was found for the two mutant TAP complexes. Thus, peptide-mediated release of MHC class I molecules is critically sensitive to mutations that abrogate the nucleotide-binding capacity of TAP.
We confirmed this phenomenon biochemically. Peptidedependent dissociation of the loading complex was studied in detergent lysates of T2 cells expressing wildtype TAP. Cellular nucleotide diphosphates and triphosphates were depleted from the lysates by apyrase (see supplementary material). Apyrase-treated and control lysates were incubated with or without peptides that bind MHC class I molecules. As shown in Figure 4b , no peptide-induced dissociation of MHC class I molecules was found in the nucleotide-depleted lysates of T2 cells expressing wild-type TAP. Incubation with apyrase alone had no detectable effect on the association between TAP and MHC class I molecules in lysates. Thus, depletion of nucleotide diphosphates and triphosphates from lysates has the same blocking effect on peptide-mediated dissociation of MHC class I molecules from TAP as mutations in the nucleotide-binding domain of TAP.
Peptide-mediated dissociation of MHC class I molecules from TAP does not depend on nucleotide hydrolysis
We also investigated the peptide-mediated dissociation in the rat cell line D7 [14] in which formation of the complex between the non-permissive transporter TAP-B and MHC class I RT1.A a molecules has been studied previously [17] . In these cells, the TAP-B transporter cannot bind (A. Seelig and J.C.H., unpublished data) or transport peptides with the carboxy-terminal arginine required for successful loading of RT1.A a [18, 19] . Thus, peptides can be used that load efficiently onto MHC class I molecules but do not serve as binding or transport substrates for TAP-B.
In experiments with D7 cells (Figure 5a ), the nonameric RT1.A a -binding peptide B6, with two strong anchor residues at position 2 and 9 [20] , dissociated digitonin-solubilised loading complexes in a clear concentrationdependent manner. A second RT1.A a -binding peptide, S2, was equally effective, whereas two non-binding peptides, A8 and S5, were unable to induce dissociation of the complex. Thus, in digitonin lysates of rat D7 cells, only appropriate peptides that bind MHC class I molecules induce release of RT1.A a from the TAP complex.
As with the T2 transfectants, peptide-dependent dissociation of the complex was inhibited if the lysate was depleted of nucleotide diphosphates and triphosphates using apyrase (Figure 5b, lanes 1-3) . Specific nucleotides could restore peptide-dependent dissociation of the loading complex in nucleotide-depleted lysates. B6 peptide-mediated dissociation of MHC class I molecules was completely restored by addition of ATP at a physiological concentration of 1 mM (lane 4).
Like other ABC transporters [21] TAP has a relatively broad nucleotide specificity. All four nucleotide triphosphates are able to power peptide translocation by TAP [22, 23] , and UTP, GTP, CTP and the nucleotide diphosphate ADP are binding competitors for ATP [24] . Figure 5b shows that peptide-mediated dissociation was completely restored to nucleotide-depleted lysates by ADP (lane 6) and by the non-hydrolysable ATP analogue, ATPγS (lane 5) but not by AMP (lane 7). UTP, CTP and GTP were also able to restore peptide-mediated release of MHC class I molecules from TAP (lanes 8-10). The broad spectrum of nucleotides which restore peptide-mediated complex dissociation provides further evidence that peptide-dependent release of MHC class I molecules is promoted by nucleotide binding of TAP. Clearly, however, the contribution of TAP to peptide-dependent release of MHC class I molecules is distinct from peptide transport as the latter is absolutely dependent on nucleotide hydrolysis [22] .
Mutant TAP is characterised by a fast turnover and persistent interaction with MHC class I molecules
A reduced supply of loadable peptides results in the accumulation of TAP-associated MHC class I molecules in the ER [17, 25] . Loading complexes assembled on TAP carrying nucleotide-binding-site mutations showed no accumulation of MHC class I molecules in the ER, however (Figures 1,4) . We therefore used pulse-chase analysis to compare the duration of the interaction between MHC class I molecules and either wild-type or mutant transporters (Figure 6a) . In T2 cells transfected with wild-type TAP, the TAP signal remained nearly constant over the whole chase period, implying almost no degradation over this interval; the signal corresponding to the TAP-associated MHC class I molecules decreased with a half-life of 100 minutes (Figure 6b ), corresponding roughly to the maturation rate of MHC class I molecules (Figure 3a) . In contrast, the mutant TAPs appeared to have an increased degradation rate, relative to the wild-type, and the apparent half-life of the TAP-associated MHC class I molecules was significantly extended. The signal intensities of mutant TAPs and associated MHC class I molecules decreased after 270 minutes to 40-45% of the initial value (Figure 6b ). In the complex between wild-type TAP and MHC class I molecules, the signal intensity corresponding to MHC class I molecules relative to TAP was reduced by ≥ 90% after a 270 minute chase, as pulse-labelled MHC class I molecules load and leave the complex (Figure 6b) . In complexes between mutant TAP and MHC class I molecules, however, no change in the ratio of the signal intensities occurred over the whole chase period (Figure 6b) , implying that the two components remained associated until both entered the degradation pathway.
The loading of MHC class I molecules by peptides was not, however, directly affected in the mutant loading complexes. Immunoisolated loading complexes from metabolically labelled T2 transfectants were loaded in 1% digitonin buffer with the A2/B5 peptide mixture and the complexes subsequently dissociated in Triton X-100. Peptide-containing molecules were then re-precipitated from the detergent mixture by the conformation-sensitive antibody, W6/32, and visualised by autoradiography following SDS-PAGE. Figure 6c shows that peptide-loaded MHC class I molecules could be recovered from both wild-type and mutant loading complexes: the low specific activity of labelled MHC class I molecules from the MUTI or MUT II complexes compared with wild-type TAP presumably results from the low turnover rate of MHC class I molecules in these complexes (Figure 6a ).
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Figure 5
Various nucleotides restore peptide-mediated release of MHC class I molecules. (a) Peptides that bind MHC class I molecules induce dissociation of TAP complexes in D7 cell lysates. Digitonin-solubilised D7 cells were supplemented with increasing concentrations (0-100 µM) of four different 9-mer peptides. RT1.A a -specific anchor residues are indicated in the sequences by bold letters. After incubation with peptide for 30 min at room temperature, TAP complexes were immunoisolated with anti-rat TAP2 antiserum and analysed by western blotting. The upper part of the blot was stained with anti-rat TAP2 antiserum, the lower part with the antiserum F87, which is specific for rat MHC class I RT1.A molecules. (b) Re-addition of nucleotides restore complex dissociation. Digitonin lysates of D7 cells were pre-incubated with or without apyrase as described in the Figure 4 legend. After depletion of nucleotides and a subsequent inactivation of apyrase by azide, the B6 peptide (10 µM) alone or in combination with 1 mM nucleotides was added to the lysates. All samples were incubated for a further 30 min at room temperature. Immunoprecipitation and western blotting was performed as described in (a). 
The integrity of the nucleotide-binding site is required for the binding of peptide to TAP
There are hints that there might be an interaction between the peptide-binding and nucleotide-binding sites of TAP [26] . We analysed this directly in streptolysin-Opermeabilised T2 transfectants using a photoreactive radioiodinated peptide substrate for TAP. TAP, with covalently-bound labelled peptide, was immunoprecipitated and analysed by SDS-PAGE. Figure 7 shows that efficient peptide-crosslinking was detected only for wildtype TAP. For both mutant transporters, no crosslinking of peptide with TAP was detected above background. In conclusion, both mutant transporters show a complete elimination of peptide-binding activity. Thus, uptake of peptide substrates by TAP depends on conformational properties determined by nucleotide binding.
Discussion
The dissociation of the MHC class I molecule from the TAP loading complex is initiated when a peptide of the appropriate structure binds to the MHC class I molecule [2, 3] , and it has been proposed that the peptide-induced conformational change in the MHC class I molecule [5] itself triggers dissociation [6] . This role of peptide is confirmed in the present study. We show, however, that peptide-mediated release of the MHC class I molecule from the TAP complex also depends on conformational properties determined by the nucleotide-binding state of TAP. When the nucleotide-binding sites of both TAP subunits were disrupted (Figure 2 ), TAP did not release MHC class I molecules in the presence of peptides that bind MHC class I molecules (Figure 4a ), although the loading complex ( Figure 1 ) and the loading of peptide into MHC class I molecules (Figure 6c ) appeared normal. A phenocopy of the TAP mutation was achieved by depletion of nucleotide diphosphates and triphosphates from cellular extracts with apyrase ( Figure 4b ); this could be reversed by re-addition of various nucleotide diphosphates and triphosphates ( Figure 5 ) that have been shown Mutations in the NBD of TAP affect binding of peptide substrates. Cells permeabilised using streptolysin O were resuspended in binding buffer and incubated with 1 µM radioiodinated and N-hydroxysuccinimidyl-4-azidobenzoate (HSAB)-conjugated peptide S8. After crosslinking, the cells were lysed and TAP was immunoprecipitated from post-nuclear supernatants with anti-rat TAP2 antiserum (upper panel). As a control, the amount of TAP in the corresponding lysates was determined by western blotting using an anti-rat TAP2 antiserum (lower panel).
TAP T A P ( w il d -t y p e ) M U T I M U T I I Peptide cross link
Cell lysate TAP Current Biology U n t r a n s f e c t e d T 2 c e ll s to bind to TAP [24] . As ADP and non-hydrolysable ATPγS also restored peptide-mediated release of MHC class I molecules, nucleotide hydrolysis is not needed for disassembly of the complex (Figure 5b ).
Although ATP hydrolysis is clearly required for substrate transport by TAP [13, 22] and other ABC transporters [21] , substantial nucleotide-induced conformational changes in the molecule seem to be associated with the transport cycle [27] . The prevailing model asserts that nucleotide-dependent conformational changes in the NBD are transduced into conformational changes in the membrane-spanning domains [27] . For P-glycoprotein, binding of MgADP and MgATP, but also non-hydrolysable ATP analogues such as MgATPγS, significantly affect protein conformation in the absence of substrate [28, 29] .
Mutations in the nucleotide-binding site not only affected the release of assembled MHC class I molecules but also eliminated the peptide-binding activity of TAP (Figure 7 ). Thus, substrate uptake by TAP depends on conformational properties determined by the nucleotide-binding state, and is therefore probably coupled to the translocation process. Communication between the NBD and substrate-binding site has been reported for ABC transporters involved in drug resistance [30, 31] , and cross-linking of P-glycoprotein with a substrate predominantly labelled fragments overlapping with transmembrane regions adjacent to the ATP-binding sites [32] . Interestingly, a lowered affinity of P-glycoprotein for substrate is detected when substrate binding is tested in the presence of vanadate, which stabilises a transition state of the P-glycoprotein transport cycle [33] . Thus, the nucleotide-empty state of TAP might resemble what is normally a transient conformation during the transport cycle in which peptide is released into the lumen of the ER. Indeed, current models of transport cycles for P-glycoprotein and cystic fibrosis transmembrane conductance regulator (CFTR) propose nucleotide free states occurring transiently during exchange of nucleotides in the NBDs [34] .
TAP molecules have been shown to bind radiolabelled peptides in vitro at 4°C in the absence of added ATP [35] . Peptide binding is strongly temperature-dependent, with very low or undetectable binding at temperatures over 4°C [35] but can be stabilised at 37°C by addition of nucleotides including ADP and ATPγS [26] . These results are fully consistent with our own analysis and together suggest conformational cross-talk between the nucleotide-binding site and the peptide-binding site. Further experiments of our own show that peptide binding also reciprocally modifies the nucleotide-binding site (P.A., J.C.H. and M.R.K., unpublished data). The location of the peptide-binding site on the TAP protein is still unknown although first steps have been taken towards its characterisation [14, 36] . It remains to be determined whether the NBDs of the two TAP chains are functionally equivalent and are both involved in the regulation of peptide uptake. Transfectants expressing a mutant TAP1 with a wild-type TAP2 and vice versa indicate functional differences between TAP1 and TAP2 (P.A., J.C.H. and M.R.K., unpublished data).
In the present experiments, MHC class I molecules associated with TAP carrying mutations in the ATP-binding site remained associated until they were degraded ( Figure 6 ). In addition, the biological half-life of the mutant transporters seems to be reduced. In a previous study, accumulation in the ER in rat cells of complexes between wild-type rat TAP and MHC class I molecules was achieved by lack of delivery of loadable peptides as a result of the presence of an inappropriate combination of TAP2 and MHC class I alleles [17] . In this latter system, however, the biological half-life of TAP was unaffected by the formation of stable complexes with MHC class I molecules (K. Gülow and M.R.K, unpublished observation). Thus, the accelerated turnover of the mutant TAP in T2 cells cannot be explained simply in terms of persisting interaction with MHC class I molecules. Mutations in the nucleotidebinding site may also cause structural instability which shortens TAP half-life. This outcome may be general for ABC transporters as mutations in the NBDs of CFTR are also characterised by increased in vivo instability [37] .
Our results provide hints towards a kinetic model of TAP function in which the binding and then the transport of peptide by TAP are kinetically coordinated with the binding of peptide to the MHC class I molecule and the subsequent release of the MHC class I molecule from the loading complex. Our findings show that the nucleotidebinding site is conformationally coupled both to the peptide-binding site and to the MHC class I molecule. TAP is probably linked to the MHC class I molecule only through the recently-described ER membrane molecule, tapasin [1] , implying that the nucleotide-mediated conformational contribution of TAP to the release of the MHC class I molecule from the complex must be transduced through tapasin. Nevertheless, tapasin deprived of its transmembrane domain, which does not interact with TAP but does interact with MHC class I molecules, appears to function as efficiently in mediating peptide loading and allowing release and maturation of MHC class I molecules as TAP-associated tapasin [38] . Presumably such complexes between MHC class I molecule and soluble tapasin can be dissociated by peptide binding to MHC class I molecules alone in the absence of nucleotide. Association of TAP with tapasin must therefore impose some structural constraint on tapasin in order to enforce nucleotide-dependence of MHC class I molecule release.
Why is loading of MHC class I molecules organised in association with TAP, and why are loading and release of MHC class I molecules apparently coordinated so intimately with the transport cycle of TAP? The two possible explanations that have been discussed in this context are, first, the zerolength diffusion path for translocated peptides and their isomolar relationship to the loading complex and, second, an opportunity for an editing reaction whereby unstably bound peptides can be exchanged for better ones. Although the first explanation makes sense, soluble tapasin, which fully replaces the tapasin defect in mutant cells but does not interact with TAP, loads a set of peptides into MHC class I molecules that are not distinguishably different at the level of analysis (bulk high-performance liquid chromatography) from that loaded in the presence of wild-type tapasin. Our idea that the non-permissive TAP-MHC class I molecule complex is formed when peptide is released by TAP would be consistent with a process of peptide editing in the TAP loading complex. The editing hypothesis, while still imprecise, has some attractions. Firstly, the stoichiometry of the loading complex appears to be 1 TAP:4 tapasin-MHC class I molecules [1] . Such a relationship, while structurally complex, is easy to relate to the accidental structural relationship between the transported peptide and the available peptide-binding grooves of MHC class I molecules. If each peptide had an opportunity under structurally favourable conditions to inspect four peptide-binding grooves for compatibility rather than just one, this would appear to present advantages. Furthermore, the persistent association of at least two chaperones (calreticulin and the disulphide isomerase ERp57) with the loading complex [39] [40] [41] suggests the potential for complex conformational behaviour which could be associated with peptide exchange on MHC class I molecules in the ER [42] . On this view, it is likely that the mechanical and kinetic coupling of loading and release of MHC class I molecules with the TAP transport cycle may have something important to do with events that occur in the loading complex after peptide has been transported to the luminal side of the ER membrane.
Conclusions
We report here that the physical interaction of the MHC class I molecule with the loading complex is regulated by nucleotide binding by TAP. Only after binding of nucleotide by TAP does the complex become permissive for peptide-induced release of the MHC class I molecule. Moreover, the integrity of the TAP nucleotide-binding site is also required for peptide binding by TAP. These results suggest that the binding and release of MHC class I molecules by the loading complex is directly coupled to the peptide-binding and transport cycle of TAP. Although much has been learned of the TAP transport system, little is known about the central processes involved in substrate translocation by any ABC transporter. Insights into the molecular mechanism by which nucleotides induce conformational changes in TAP may have to wait for a full-scale structure-function analysis and extensive inferences from related transporters.
Materials and methods
Cell lines and cell culture
T2 is a human lymphoblastoid cell line which lacks both TAP genes, and expresses only the HLA-A2 and HLA-B5 MHC class I molecules [43] . T2 transfectants containing rat TAP1 a and rat TAP2 a , which have been described previously [7] , were cultured in IMDM (Gibco BRL) supplemented with 1 mg/ml G418 (PAA, Cölbe). D7 cells, created by double transfection of the rat T-cell lymphoma line C58 with cDNAs encoding RT1.A a and TAP2 u [14] , were maintained in culture as described previously [17] .
Cloning and expression of mutant TAP
Mutagenesis of the Walker A site in rat TAP2 a and TAP1 a cDNA [44, 45] was performed using the pALTER-1 in vitro mutagenesis system (Promega) according to the manufacturer's instructions. Mutagenic oligonucleotides were: MUT I, 5′-GGTGCTCTTCACTGACC-CATTGGGCACCACCAAAGC-3′; and MUT II, 5′-GGTGCTCTTGCT-TGACCCATTGGGGCTCACCAAAGC-3′. The mutated constructs were subcloned in pHβAPr-1-neo [46] and cotransfected with pPUR (Invitrogen) into T2 cells by electroporation using a Bio-Rad gene pulser at 270 V/550 µF. After selection with puromycin, transfectants were subcloned and screened for expression of rat TAP by western blotting. Stable transfectants were maintained in IMDM supplemented with 750 ng/ml puromycin.
Immunoprecipitation and western blotting
Cells were solubilised in lysis buffer (50 mM Tris/HCl, pH 7.4, 150 mM NaCl) containing 1% digitonin (Fluka) or 1% Triton X-100 (Sigma). Lysis buffers were occasionally supplemented with 3 mM MgCl 2 , 5 mM iodoacetamide (Sigma) and 0.5 mM PMSF (Boehringer Mannheim).
Immunoprecipitations with anti-rat TAP2 antiserum were performed as described previously [17] . For characterisation of the complex, affinitypurified anti-rat TAP2 antiserum was covalently coupled to oxirane acrylic beads (Sigma) [47] . Competitive elution of TAP complexes and western blotting was performed as described previously [17] .
Pulse-chase analysis
Pulse-chase experiments were performed as described previously [17] .
Flow cytometry
Cells were washed twice with DFN (PBS, 10% FCS, 0.01% NaN 3 , 9 mM CaCl 2 ⋅2H 2 O, 5 mM MgCl 2 ⋅6H 2 O) and incubated with monoclonal antibody 4E (anti-HLA-B antibody) for 30 min on ice, washed three times in DFN and incubated with FITC-conjugated anti-mouse IgG (Dianova) for a further 30 min. Analysis was performed on a FACSScan flow cytometer (Becton Dickinson).
Transport assay
Cells (2 × 10 6 ) were permeabilised with streptolysin O (2 U/ml; Murex). After washing with PBS, 0.5 µM radioiodinated peptide S8 (TVDNK-TRYR), 10 mM ATP and incubation buffer containing 50 mM Hepes pH 7.5, 250 mM sucrose, 150 mM CH 3 COOK, 5 mM (CH 3 COO) 2 Mg.4H 2 O, 1 mM DTT, 1 mM leupeptin (Boehringer Mannheim), 1 mM Pefabloc (Boehringer Mannheim) and 1.8 µg/ml aprotinin (Sigma) were added and incubated for 10 min at 37°C. Following lysis with 20 mM Tris-HCl pH 7.5, 500 mM NaCl, 1 mM MgCl 2 , 1 mM CaCl 2 , 0.1% Triton X-100 (Sigma), 0.1% Nonidet P-40 (Sigma), transported glycosylated peptides were isolated with Con A-sepharose (Pharmacia) and quantitated by gamma counting.
Nucleotide-binding assay
Cells were washed in TBS containing 3 mM MgCl 2 and disrupted by freezing and thawing. The suspension was spun at 1000 × g for 10 min at 4°C. The supernatant was centrifuged for 1 h at 100,000 × g. Membrane pellets from 10 7 cells were resuspended in 500 µl lysis buffer, composed of TBS/MgCl 2 containing 2% CHAPS (Sigma), and incubated for 30 min on ice, followed by centrifugation at 10,000 × g for 30 min. Aliquots corresponding to 1.5 × 10 6 cells were incubated with 50 µl nucleotide-agarose (Sigma) for 1 h at 4°C in 500 µl lysis buffer. After washing with lysis buffer, proteins were eluted with SDS-containing sample buffer and analysed by western blots probed for TAP1 and TAP2.
Peptide crosslinking assay
Cells (2 × 10 6 ) were permeabilised with streptolysin O (2 U/ml; Murex). After washing with cold PBS, cells were resuspended in 100 µl binding buffer, which contained 50 mM Tris-HCl, pH 7.5, 5 mM (CH 3 COO) 2 Mg⋅4H 2 O, 1 mM CaCl 2 , 1 mM DTT, 1 mM leupeptin (Boehringer Mannheim), 1 mM Pefabloc (Boehringer Mannheim), 1.8 µg/ml aprotinin (Sigma) and 0.1% dialysed denatured BSA. Cells were incubated with 1 µM radioiodinated and HSAB-conjugated peptide S8 (TVDNKTRYR). Crosslinking was induced by irradiation with a UV lamp at 254 nm for 5 min on ice. Cells were lysed by adding 1% Nonidet P-40 (Sigma) in PBS. After a 30 min incubation, TAP was immunoprecipitated from lysates with anti-TAP2 antibody.
Supplementary material
Supplementary material including additional methodological detail is available at http://current-biology.com/supmat/supmatin.htm.
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